Robert B. and Gail B. of Georgia have filed an Actos lawsuit against Takeda Pharmaceuticals for allegedly causing the injured plaintiff to develop bladder cancer.

Robert claims in the Actos bladder cancer lawsuit that as a direct result of ingesting the type-2 diabetes drug he developed and is currently battling bladder cancer.

Robert had reportedly been prescribed Actos by his physician because he had not reacted well with first-line treatment options. Due to its aggressive treatment mechanism, Actos is often prescribed when other drugs have shown not to work with the patient. Robert is one of these patients. He was prescribed Actos from July 2006 to February 2008, according to the Actos bladder cancer lawsuit.

While Robert initially responded well to the drug, he started developing unexplained symptoms that were not mentioned on the Actos label. Additionally, at the time the bladder cancer symptoms first started appearing, it had been several years after he stopped taking Actos, the Actos lawsuit alleges.

Robert was officially diagnosed with bladder cancer on Sept. 29, and has since been under extensive medical treatment for this aggressive disease.

Bladder cancer is one of the most aggressive and fast-spreading cancers, with patients often only given several years of life expectancy after diagnosis.

While Robert and his wife are doing everything in their power to prevent prevent the disease from spreading, the injured plaintiff filed the Actos lawsuit against Takeda for allegedly causing this complication.

Ever since his diagnosis, Robert reportedly has to regularly see his doctor, take a variety of medications, undergo cancer treatments, and has incurred massive medical expenses. Robert is filing the Actos bladder cancer lawsuit against Takeda, claiming that the company had failed in its duty to protect him and other consumers from Actos bladder cancer.

Robert had found out about the potential correlation between Actos and bladder cancer through U.S. Food and Drug Administration (FDA) announcements and came to the decision to file this Actos lawsuit, along with thousands of other plaintiffs with similar claims.

Robert’s Actos lawsuit will added to the multidistrict litigation currently underway in a Louisiana federal court where it will stand alongside other Actos lawsuits claiming similar injuries.

Each of these plaintiffs state that bladder cancer was not on Actos’ warning label, and the company had failed to notify of them about the risk. Robert states that he never would have used Actos if he had known about the possibility of bladder cancer.

For being allegedly responsible for manufacturing, selling, distributing, and marketing a dangerous drug, Robert and his wife are suing Takeda. The charges include negligence, false advertising, concealing information, and misrepresenting a product.

The Actos Bladder Cancer Lawsuit is Case No. 6:14-cv-03011, and the Actos MDL is In Re: Actos Product Liability Litigation, MDL No. 2299, both in the U.S. District  Court for the Western District of Louisiana.

Overview of Actos Complications

Actos was first approved by the FDA in July 1999 to be a type-2 diabetes treatment drug. It has become well-known to be an aggressive treatment option, earning it the place of being an alternative choice of diabetic medications.

This drug specifically reacts to the presence of insulin, and is therefore useless to type-I diabetes. Actos is a part of an insulin-sensitizing diabetes drugs called thiazolidinediones.

Actos is popular among patients with more resilient type-2 diabetes and has proved to be a fruitful venture for Takeda. Since 2010, the Japanese pharmaceutical giant has been at the center of major criticism from American healthcare providers and their patients for the deadly Actos side effect.

The concern of Actos bladder cancer gained traction on Sept. 17, 2010, when the FDA made a safety announcement regarding this potential link. The agency made this announcement after the results of a 10-year study conducted by Kaiser Permanente were released, which found a strong likelihood of bladder cancer development from Actos ingestion.

Furthermore, the Actos study found that the risk almost doubled if the patient stayed on Actos for a year or more. It has been alleged that Takeda knew about the possibility of bladder cancer but took no effort to protect the patients.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual Actos lawsuit or Actos class action lawsuit is best for you. [In general, Actos bladder cancer lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More